Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

RealView's 3-D holographic projection of a heart
Feature | Dave Fornell

The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the ...

Home December 21, 2012
Home
Technology

December 20, 2012 — BlipCare has presented the world's first Wi-Fi blood pressure monitor on international crowd funding ...

Home December 20, 2012
Home
News

November 30, 2012 — St. Jude Medical Inc. announced that the company’s EnligHTN renal denervation system provides a safe ...

Home November 30, 2012
Home
Boston Scientific Renal Denervation Vessix Vascular
Feature

November 8, 2012 — Boston Scientific Corp. is extending its reach into the renal denervation market by signing a ...

Home November 08, 2012
Home
Feature

November 7, 2012 — Kona Medical Inc. announced the initiation of the first clinical study of its device therapy for drug ...

Home November 07, 2012
Home
News

November 5, 2012 — ReCor Medical reported one-year follow-up data on patients who have been treated via renal ...

Home November 05, 2012
Home
News

October 3, 2012 — When multiple medications prove ineffective, patients with high blood pressure are currently left with ...

Home October 03, 2012
Home
News

August 15, 2012 — Sound Interventions Inc. has released three-month data from the company's first-in-human clinical ...

Home August 15, 2012
Home
News

June 1, 2012 Kona Medical Inc. announced it has raised $30 million in Series C financing to advance its novel ...

Home June 01, 2012
Home
News

May 18, 2012 -- St. Jude Medical Inc., a global medical device company, announced that preliminary data demonstrated the ...

Home May 18, 2012
Home
Feature

May 15, 2012 – St. Jude Medical Inc. announced CE mark approval and launch of its EnligHTN renal denervation system ...

Home May 15, 2012
Home
News

May 9, 2012 — Sound Interventions Inc. announced the successful completion of the company's first-in-human renal ...

Home May 09, 2012
Home
News

May 4, 2012 - Medtronic Inc. announced six-month pooled outcomes from randomized and crossover patients in the ...

Home May 04, 2012
Home
News

May 2, 2012 — Vessix Vascular Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology ...

Home May 02, 2012
Home
News

April 11, 2012 — ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked ...

Home April 12, 2012
Home
Subscribe Now